MohammedAmeir Abdul KarimAl-JumayliMD

PubMed

• 75 citations
  Factors associated with focal lamina cribrosa defects in glaucoma.
  Sung Chul Park, Anthony T. Hsu, Daniel Su, Joseph L. Simonson, Mohammed Al-Jumayli
  Investigative Ophthalmology & Visual Science. 2013-12-30
• 19 citations
  Immuno-Oncotherapeutic Approaches in Advanced Hepatocellular Carcinoma
  Robin Park, Fariha Faruk Eshrat, Mohammed Al-Jumayli, Azhar Saeed, Anwaar Saeed
  Vaccines. 2020-08-08
• 3 citations
  CAR T-cell therapy has comparable efficacy with autologous transplantation in older adults with DLBCL in partial response.
  Othman S Akhtar, Biwei Cao, Xuefeng Wang, Pallawi Torka, Mohammed Al-Jumayli
  Blood Advances. 2023-10-10

Journal Articles

• Immune Checkpoint Inhibitors versus VEGF Targeted Therapy as Second Line Regimen in Advanced Hepatocellular Carcinoma (HCC): A Retrospective Study  
  A. Saeed, H. Hildebrand, R. Park, M. Al-Jumayli, S. Abbasi, T. Melancon, A. Saeed, R. Al-Rajabi, A. Kasi, J. Baranda, S. Williamson, W. I Sun, Journal of Clinical Medicine, 8/16/2020
• Immuno-Oncotherapeutic Approaches in Advanced Hepatocellular Carcinoma  
  Robin Park, Fariha Eshrat, Mohammed Al-Jumayli, Azhar Saeed, Anwaar Saeed, Multidisciplinary Digital Publishing Institute, 7/11/2020
• Association of Serrated polyps with extracolonic malignancies.  
  Mohammed AL-Jumayli,MD,D. Goldsmith, J Rogart,MD, The American Journal of Surgical Pathology
• Primary Cardiac Burrkit Lymphoma: Characteristics, Clinical Presentation and Outcome  
  Mohammed Al-Jumayli,MD, E.Chen,MD, Blood/American Society of Hematology, 12/3/2015
• Join now to see all

Abstracts/Posters

• Neoadjuvant cisplatin based therapy in bladder cancer: Is less enough?
  Saqib Abbasi, Mohammed Al-Jumayli, Hannah Hildebrand, Elizabeth Marie Wulff-Burchfield, Eugene K Lee, John A Taylor, Jeffrey Holzbeierlein, Grace Martin, Rahul Atul Pa..., Journal of Clinical Oncology, Chicago,USA, 6/1/2020
• Clinical Outcomes of different management modalities of Anaplastic Thyroid Cancer: A single Center Experience
  Mohammed Al-Jumayli, Hameem Kawsar, Prakash Neupane, International Journal of Radiation Oncology• Biology• Physics, Arizona, USA, 2/24/2020
• Immunotherapy versus biologics as second-line therapy in advanced hepatocellular carcinoma (HCC).
  Mohammed Al-Jumayli, Hannah Hildebrand, Saqib Abbasi, Anup Kasi, Anwaar Saeed, American Society of Clinical Oncolog GI , JCO, US, 1/27/2020
• Outcomes of DNA repair-deficient pancreatic cancers: KU Cancer Center experience
  Mohammed Al-Jumayli,MD Anup Kasi,MD, ACCR 2019-pancreatic cancer advances in science and clinical care, Boston, 9/6/2019
•  ASCO 2019;: "Potential interaction of radiation therapy, antibiotic, and steroid use in non-small cell lung cancer patients treated with checkpoint inhibitors; A ret...
  F.Wang; Kevin D'Rummo, Mohammed AL-Jumayli, Lei Pei, Chao Huang, Journal of Clinical Oncology 37, 2019 (suppl; abstr e20724), Chicago, USA, 6/1/2019
• Neoadjuvant chemoradiotherapy with concurrent cisplatin/5-fluorouracil is associated with improve survival compared to carboplatin/paclitaxel in patients with locally ...
  Mohammed AL-Jumayli,,Saqib Abbasi, Anwaar Saeed, .Journal of Clinical Oncology 37 (4_suppl), 165-165, San Francisco, USA, 1/24/2019
• • Hemolytic Uremic Syndrome Associated With Clopidogrel Use
  Mohammed Al-Jumayli,MD, Linda Shuhu,MD, D.Goldsmith,MD, ACP meeting, 4/13/2014
• Join now to see all

Lectures

• Immunotherapy versus biologics as second-line therapy in advanced hepatocellular carcinoma (HCC). 
  ASCO Gastrointestinal Cancers Symposium - San Francisco, CA - 1/24/2020